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S Y N 0 P S I S 
Objective. Although the state of Oklahoma has traditionally reported very 
high incidence rates of Rocky Mountain spotted fever (RMSF) cases, the 
incidence of RMSF among the American Indian population of the state has 
not been studied. The authors used data from several sources to estimate 
the incidence of RMSF among American Indians in Oklahoma. 
Methods. The authors retrospectively reviewed an Indian Health Service 
(IHS) hospital discharge database for 1980-1996 and available medical 
charts from four IHS hospitals. The authors also reviewed RMSF case report 
forms submitted to the Centers for Disease Control and Prevention (CDC) 
for 198 1-1996. 
Results. The study data show that American Indians in the IHS Oklahoma 
City Area were hospitalized with RMSF at an annual rate of 48.2 per million 
population, compared with an estimated hospitalization rate of 1 6.9 per mil- 
lion Oklahoma residents. The majority of cases in the IHS database (69%) 
were diagnosed based on clinical suspicion rather than laboratory confirma- 
tion. The incidence of RMSF for Oklahoma American Indians as reported to 
the CDC was 37.4 cases per million, compared with 21.6 per million for all 
Oklahoma residents (RR 1.7, 95% confidence interval [CI] 1.5, 2. 1). 
Conclusions. Rates derived from the IHS database may not be comparable to 
state and national rates because of differences in case inclusion criteria. How- 
ever, an analysis of case report forms indicates that American Indians in Okla- 
homa have a significantly higher incidence of RMSF than that of the overall Okla- 
homa population. Oklahoma American Indians may benefit from educational 
campaigns emphasizing prevention of tick bites and exposure to tick habitats. 
Address correspondence to: 
Dr. McQuiston, CDC, MS G-13, 1600 Clifton Rd., Atlanta GA 30333; tel. 404-639-0041; fax 404-639-2778; e-mail 
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R o ocky Mountain spotted fever (RMSF), a 
potentially fatal illness caused by the rick- 
ettsial agent Rickettsia rickettsii, is transmit- 
ted to humans through tick bites. RMSF is 
endemic throughout the southeastern and 
south central United States, and people residing in these 
areas are at high risk for infection.' Clinical signs and 
symptoms of RMSF include fever with acute onset, 
headache, myalgia, and rash, often on the palms and 
soles.' Severe RMSF infection may be characterized by 
respiratory distress, renal failure, bleeding disorders, 
myocarditis, and encephalitis.2 With appropriate antibi- 
otic treatment, case-fatality ratios in the range of 2% and 
10% are expected; fatality ratios as high as 30% were 
observed prior to the late 1940s, when broad-spectrum 
antibiotics became available.' 
The Centers for Disease Control and Prevention 
(CDC) collects national data on RMSF using two dis- 
tinct reporting systems: the National Electronic 
Telecommunications System for Surveillance (NETSS) 
and case report forms (CRFs) submitted by state health 
departments. State health departments electronically 
submit numbers of laboratory-confirmed cases to the 
CDC on a weekly basis through NETSS. In addition, 
state health departments are encouraged to submit com- 
pleted CRFs on RMSF cases; these forms provide useful 
data on patient demographics, laboratory test results, 
and case outcomes. 
National annual incidence rates for RMSF are cal- 
culated using NETSS data, and generally range from 2 
cases per million population to 5 cases per million pop- 
ulation. 13 Oklahoma has traditionally reported very 
high RMSF incidence rates; cases from this state 
accounted for more than 11% of all NETSS cases for 
1980-1996. 3 Although American Indians make up an 
estimated 8% of the Oklahoma population,4 the inci- 
dence of RMSF in this population has not been evalu- 
ated. American Indians in Oklahoma may be at particu- 
lar risk for RMSF infection because many live in rural 
environments and are involved in occupational or recre- 
ational activities that could increase their risk for tick 
bites. 
Comprehensive health care is available to people of 
American Indian descent who are members of federally 
recognized tribes through the Indian Health Service 
(IHS), an agency of the US Department of Health and 
Human Services. Treatment is offered at designated 
IHS- or tribally run clinics and hospitals, or through pri- 
vate contractual arrangements. Approximately 20% of 
American Indians who use IHS health care services 
reside in the Oklahoma City area,5 one of 12 IHS Areas 
across the nation. The Oklahoma City Area, which 
spans the entire state of Oklahoma, part of Kansas, and 
part of Texas, is home to 37 different federally recog- 
nized tribes; inpatient services are provided by a total of 
seven IHS tribally run or contract facilities. Although 
the Oklahoma City Area serves some people who reside 
in Kansas and Texas, they make up a relatively small 
percentage (<3%) of the IHS user population in the 
Oklahoma City Area (Personal communication, Dan 
Cameron, PhD, Statistical Services, Oklahoma City 
Area, IHS, October 11, 2000). 
For the present study, we estimated RMSF incidence 
rates for American Indians in Oklahoma according to 
two different reporting mechanisms. We first examined 
hospital discharge records for 1980-1996 for the seven 
Oklahoma City Area IHS inpatient facilities to estimate 
RMSF hospitalization rates for the Oklahoma American 
Indian population. We then compared these rates to esti- 
mated state and national hospitalization rates derived 
from NETSS data. 
We evaluated the accuracy of the IHS hospital dis- 
charge reporting system for RMSF by conducting med- 
ical chart reviews of available records of RMSF cases 
from four IHS hospitals. 
We also analyzed RMSF CRFs submitted to the 
CDC for 1981-1996 to compare the incidence of RMSF 
for Oklahoma American Indians to that for the general 
Oklahoma and US populations. 
M E T H 0 D S 
IHS hospital discharge data. We obtained hospital 
discharge data reported to the IHS from the Oklahoma 
City Area for calendar years 1980 through 19966 (Per- 
sonal communication, Yolinda Cadman, Information 
Technology Support Center, IHS, February 26, 1999, for 
October-December 1996 data). These data consisted of 
patient discharge records obtained from all seven of the 
IHS-operated, tribally operated, and contracted commu- 
nity hospitals in the Oklahoma City area that provided 
care to eligible American Indians.7 
The hospital discharge data provided information on 
individuals who were hospitalized at IHS inpatient facili- 
ties. These data did not include information on people 
treated as outpatients, or information on American Indi- 
ans who may have obtained health care services at non- 
IHS facilities. In addition, no data were included on 
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American Indians who were not members of federally 
recognized tribes, because these individuals do not have 
access to IHS health care services. 
We selected the first hospital discharge record with a 
diagnosis of RMSF for each person, defined as a hospi- 
talization for which the International Classification of 
Diseases, 9th Revision, Clinical Modification (ICD-9- 
CM)8 code 082.0 was listed as one of up to six diagnoses 
on the IHS patient record. Six patients had a second 
hospitalization with a diagnosis of RMSF (ICD-9-CM 
082.0) or unspecified rickettsioses (ICD-9-CM 082.9) 
within five days of their first discharge; for these cases, 
we considered both hospitalizations part of the same 
event. 
We estimated the annual RMSF hospitalization rate 
for Oklahoma American Indians by calculating the num- 
ber of hospitalized cases per million Oklahoma City Area 
IHS users. The number of Oklahoma City Area IHS 
users was determined for each year from 1980 through 
1996 by using the 1996 IHS estimate of the Area's user 
population and adjusting backward for annual changes 
based on annual percentage changes in the size of the 
Area's IHS service population.5 
Estimated state and national hospitalization rates. 
To obtain Oklahoma state and national estimates of 
RMSF hospitalization rates, we first multiplied the 
annual numbers of NETSS-reported RMSF cases by the 
expected frequencies of hospitalization calculated from 
CRF data for 1981-1996. The expected frequency of 
hospitalization for laboratory-confirmed RMSF cases for 
this period averaged 68.9% for the United States and 
63.6% for Oklahoma (Unpublished data, Viral and Rick- 
ettsial Zoonoses Branch, CDC). We defined national 
and state RMSF hospitalization rates as the estimated 
number of hospitalized RMSF cases per million persons 
per year.9 
Risk ratios (RRs) with 95% confidence intervals (CIs) 
were calculated using Poisson regression analysis.'0 
Medical chart review. Prior to the medical chart 
review, the project was reviewed and approved by human 
subject review boards of the IHS, the Oklahoma City 
IHS Area, and appropriate tribal councils. 
We reviewed available medical charts containing 
RMSF diagnoses from four Oklahoma City Area IHS 
hospitals, collecting additional information on clinical 
signs, disease severity, and how the diagnosis of RMSF 
was made. The four hospitals accounted for more than 
75% of the 186 reported cases, and charts were available 
for 78 of the 141 RMSF-related hospitalizations at these 
four facilities. 
We defined cases of RMSF according to national 
reporting guidelines." Specifically, a confirmed case of 
RMSF required laboratory evidence of disease in an 
individual with a compatible clinical illness. Labora- 
tory confirmation consisted of any of the following: a 
fourfold change in antibody titer measured by 
immunofluorescence (IFA), complement fixation 
(CF), latex agglutination (LA), microagglutination 
(MA), or indirect hemagglutination antibody (IHA) 
tests of paired acute- and convalescent-phase serum 
samples; a positive polymerase chain reaction (PCR) 
assay; a positive immunohistochemistry; isolation of R. 
rickettsii from a clinical specimen; a single IFA titer 
>64, a single CF titer >16; a fourfold change in Proteus 
OX2/19/K titer or a single titer >320; or a single LA, 
IHA, or MA titer ?128." We classified clinically com- 
patible cases that did not meet the definition of a con- 
firmed case as suspected cases. 
We compared confirmed cases with suspected cases 
with respect to patient age and length of hospital stay 
using the Wilcoxon rank-sum test.'2 RRs with 95% CIs 
were calculated for dichotomous variables. 
CRF data submitted to CDC. We calculated 
average annual incidence rates for RMSF using the 
CRFs submitted to the CDC for 1981-1996. Only labo- 
ratory-confirmed RMSF cases were included in the 
analysis of these data. 
Incidence was calculated as the total number of 
laboratory-confirmed RMSF cases per million popula- 
tion, using intercensal population estimates for each year 
from 1981 through 1996 as denominators.9 If the record 
listed a race/ethnicity classification of American 
Indian/Alaska Native and Oklahoma residence, we con- 
sidered the patient an Oklahoma American Indian for 
the purposes of the present study. 
We compared rates of CRF-reported RMSF cases 
across racial/ethnic groups for the state of Oklahoma for 
1981-1996. RRs with 95% CIs were calculated using 
Poisson regression analysis.'0 
RE S U LTS 
IHS hospital discharge data. For 1980-1996, 186 
cases of RMSF were reported to the IHS from seven 
IHS inpatient facilities in the Oklahoma City Area. The 
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estimated average annual RMSF hospitaliza- 
tion rate for Oklahoma American Indians 
based on these data was 48.2 cases per mil- 
lion population. 
Two of the Oklahoma City Area IHS 
patients with RMSF died, for a case-fatality 
ratio of 1.1%. Of the 186 cases reported to 
the IHS from the Oklahoma City Area, 146 
(78.5%) had a primary diagnosis of RMSF. 
Other ICD-9-CM codes that were fre- 
quently listed as co-diagnoses included 
275.5 (volume depletion; 9.7% of patients), 
287.5 (thrombocytopenia; 7.5%), 780.6 
(fever; 6.5%), 079.9 (unspecified viral or 
chlamydial infection; 3.2%), and 288.0 
(agranulocytosis; 2.7%). 
Estimated state and national hospital- 
ization rates. Using NETSS data, we 
calculated an average estimated RMSF 
hospitalization rate for Oklahoma of 16.9 
cases per million population (including 
the American Indian population) and an 
average rate for the United States of only 2.1 
cases per million population (see Figure 1). 
RMSF hospitalization rates were signifi- 
cantly higher for Oklahoma American Indi- 
ans than for all Oklahoma residents (RR = 
2.9; 95% CI 2.4, 3.3). 
Medical chart review. We reviewed med- 
ical charts for 78 of the 186 RMSF hospital- 
izations in the Oklahoma City Area for 
1980-1996. Of these 78 patients, only 24 
(30.8%) met the definition for laboratory- 
confirmed RMSF. In the remaining 54 
cases, RMSF was suspected on the basis of 
clinical signs but was never shown to be the 
cause of illness by laboratory tests. Cases of 
laboratory-confirmed RMSF did not differ 
appreciably from suspected cases with 
respect to the length of hospital stay 
(median of 4 days for laboratory-confirmed 
and median of 3 days for suspected) or the 
sex of the patient. Median patient age was 
lower for laboratory-confirmed cases (10.5 
years) than for suspected cases (22 years), 
although not significantly (P = 0.36). 
Figure 1. Estimated average annual Rocky Mountain spotted 
fever hospitalization rates, 1980-1996, according to discharge 
records from Indian Health Service (IHS) Oklahoma City 
Area inpatient facilities and the National Electronic 
Telecommunications System for Surveillance (NETSS) 
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Figure 2. Average annual incidence of Rocky Mountain spotted 
fever, Oklahoma, 1981-1996, according to Case Report Forms 
submitted to the Centers for Disease Control and Prevention 
40 37.4 
3 I 
30 
0* 
o> 25 
6> 21.6 
o 20 
I00 
& IS 
United States Oklahoma American Indians 
in Oklahoma 
472 PUBLIC HEALTH REPORTS * SEPTEMBER/OCTOBER 2000 * VOLUME 1 15 
RES EARC H ARTI C LE S 
Table. Clinical history associated with cases of Rocky Mountain spotted fever among Oklahoma City Area 
American Indians, 1980-1996, according to inpatient medical charts from four Indian Health Service hospitals 
(N = 78 cases) 
Confirmed cases Suspected cases 
n = 24 n = 54 
Clinical signs and symptoms Number Percent Number Percent Risk ratio 95% Cl 
Tick bite within 2 weeks 5....... i 62.5 38 70.4 0.9 0.6, 1.3 
Fever ...................... 21 87.5 52 96.3 0.9 0.8, 1.1 
Headache ................... 17 70.8 37 68.5 1.1 0.8, 1.5 
Myalgia ..................... 16 66.7 36 66.7 1.0 0.7, 1.4 
Rash anywhere on body I....... 15 62.5 33 61.1 1.0 0.7, 1.5 
Rash on palms and soles ....... I 1 45.8 1 1 25.6 2.3 1.1, 4.5 
Severe disease ............... 6 25.0 4 7.4 3.4 1.1, 10.9 
Cl = confidence interval 
The frequencies of specific clinical signs (see Table) 
indicate that the clinical characteristics in laboratory- 
confirmed cases of RMSF were in many instances simi- 
lar to those in suspected cases. However, in confirmed 
cases, patients were significantly more likely to have a 
history of rash on the palms and soles and severe dis- 
ease, characterized by respiratory distress, encephalitis 
or meningitis, or coagulopathy. 
In 15 (27.8%) of the 54 suspected RMSF cases, we 
found no record of any diagnostic test being conducted 
during the course of clinical illness. In 20 cases 
(37.0%), we found a record of a single negative antibody 
test for RMSF, and in 19 cases (35.2%) there were 
records of negative serologic tests on both acute- and 
convalescent-phase serum samples. 
CRF surveillance data submitted to CDC. Infor- 
mation on patient race/ethnicity was available for 1,113 
confirmed cases of RMSF reported in Oklahoma for 
1981-1996. Of these, 140 cases (12.6%) occurred in 
people described on the CRF form as American Indians. 
Oklahoma American Indians had a significantly higher 
risk for RMSF (37.4 cases per million population) than 
residents of the state of Oklahoma (21.6 cases per mil- 
lion; RR = 1.7; 95% CI 1.5, 2.1) or of the United States 
(1.5 cases per million) (Figure 2). 
In 75 (56.0%) of the 134 Oklahoma American 
Indian cases for which hospitalization status was 
known, patients were hospitalized during the clinical 
course of illness. American Indians in Oklahoma were 
hospitalized when diagnosed with RMSF at a slightly 
lower rate than members of other racial/ethnic groups in 
Oklahoma (RR = 0.9; 95% CI 0.7, 1.0), although this 
difference was not significant. Fatal outcomes were 
reported for 181 US residents (including Oklahoma res- 
idents) (case-fatality ratio = 3.4%) and 27 Oklahoma 
residents (case-fatality ratio = 2.4%) in 1981-1996. 
Only one of the people who died in Oklahoma was an 
American Indian; the case-fatality ratio of 0.7% was not 
significantly different from that for other racial/ethnic 
groups in Oklahoma. 
D I S C U S S I O N 
The average annual RMSF hospitalization rate for 
American Indians in Oklahoma based on IHS hospital 
discharge summaries was higher than NETSS-based 
estimated hospitalization rates for the general popula- 
tions of Oklahoma and the United States. These find- 
ings provide suggestive evidence that Oklahoma Ameri- 
can Indians experience an RMSF rate higher than that 
of the general Oklahoma population. However, our 
review of hospital medical charts indicated that many 
RMSF cases identified through IHS hospital discharge 
records did not meet the criteria for laboratory confir- 
mation. Thus, rates derived from these data may not be 
comparable to rates derived from NETSS data due to 
differences in case inclusion criteria. 
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An analysis of data from a second reporting system, 
CRF forms submitted to the CDC by state health 
departments, provided additional evidence that reported 
rates of confirmed RMSF were significantly higher 
among Oklahoma American Indians than among the 
general Oklahoma population. 
The data reported here are subject to some limita- 
tions. Some case patients may have been non-residents 
of the state of Oklahoma. Some RMSF cases may have 
been missed in the IHS hospital discharge records due 
to underreporting or incomplete hospital records. Fur- 
thermore, the IHS hospital discharge records may not 
have included all American Indians diagnosed with 
RMSF, because some individuals may have sought care 
at non-IHS hospitals. In addition, the IHS hospital 
database only provided information on hospitalized 
cases and therefore did not include RMSF cases treated 
on an outpatient basis. 
Another limitation of our study is the possibility of 
underreporting of RMSF cases by physicians or state 
health departments, due to the inevitable problems with 
passive surveillance or due to difficulties in meeting the 
case definition for confirmed cases. Because people 
who present with RMSF frequently do not have 
detectable antibody titers to R. rickettsii during the first 
10 days of their illness, some physicians may not rou- 
tinely use laboratory tests to aid their diagnostic and 
treatment decisions.'3"14 In the present study, the IHS 
hospital discharge records showed that nearly 45% of 
the patients with a reported diagnosis of RMSF either 
had no serum tested or had only a single serum sample 
submitted for testing. Another complicating factor is 
that within the last decade additional tickborne agents 
that are either endemic (Ehrlichia chaffeensis) or likely 
to be endemic (E. ewingii) to Oklahoma have been 
identified as human pathogens that cause diseases simi- 
lar to RMSF.'-37 Serologic tests for these agents were 
not widely available before 1992, and as of 1999, the 
human ehrlichioses had not been assigned unique ICD- 
9-CM designations. 
The finding that many American Indians in the 
Oklahoma City Area with suspected RMSF presented 
with an illness similar to, but less severe than, those 
with confirmed RMSF further highlights the interesting 
possibility that another tickborne illness, such as ehrli- 
chiosis, may be contributing to disease in this popula- 
tion. A study in North Carolina (a state that reports 
rates of RMSF and ehrlichiosis similar to those seen in 
Oklahoma" 3",6) found that febrile patients with a history 
of tick bites were as likely to show serologic evidence of 
exposure to ehrlichial agents as to RMSF.'8 Support for 
this hypothesis is found in the high percentage of sus- 
pected RMSF cases for which tick bite was reported in 
the two weeks preceding illness (70%) in the present 
study. Furthermore, confirmed cases of RMSF were 
more than three times as likely as suspected cases to be 
associated with severe disease, characterized by 
encephalitis, respiratory distress, or coagulopathy. 
Patients in laboratory-confirmed cases were also 
younger on average than those in suspected cases, 
although not significantly, and were more than two 
times as likely to report a rash on the palms or soles. In 
contrast to RMSF, ehrlichiosis is typically a less serious 
illness; it affects older age groups more frequently than 
children; it has a lower rate of complications; it less fre- 
quently causes a rash; and when present, the rash is not 
typically found on the palms or soles. '9'20 
Our results suggest that American Indians in Okla- 
homa have a higher rate of RMSF than the overall Okla- 
homa population. If true, this may be due to differences 
in frequency of exposure to ticks. Ticks infected with 
RMSF may sometimes be highly concentrated in focal 
geographic areas, and may thus contribute to high rates 
of transmission of rickettsiae in these areas.2"22 
Although there are no Indian reservations in Oklahoma, 
people with cultural ties to specific tribes may live close 
to each other. Because our study also indicated that 
other tickborne diseases, such as ehrlichiosis, may be 
contributing to RMSF-like illness among this popula- 
tion, American Indians in Oklahoma may benefit from 
educational campaigns emphasizing prevention of tick 
bites and avoiding exposure to tick habitats. Efforts to 
identify the etiologic cause(s) of disease in people who 
present with symptoms similar to those of RMSF 
should include requests for testing against ehrlichial 
antigens as well as Rickettsia rickettsiae. 
The authors thank John O'Conner for editorial assistance; Aaron Curns for 
technical assistance; Chris Paddock for manuscript review; Yolinda Cadman, 
Glenn Melton, and Dan Cameron, PhD, for access to IHS data; and the staff 
members of the Oklahoma Area IHS hospitals we visited. The views 
expressed are the authors' and do not necessarily represent those of the 
Indian Health Service or the other agencies with which the authors are 
affiliated. 
474 PUBLIC HEALTH REPORTS * SEPTEMBER/OCTOBER 2000 * VOLUME I 15 
RES EARC H ARTI C LES 
References 
1. Dalton MJ, Clarke MJ, Holman RC, Krebs JW, Fishbein DB, Olson JG, 
Childs JE. National surveillance for Rocky Mountain spotted fever, 
1981-1992: epidemiologic summary and evaluation of risk factors for 
fatal outcome. Am J Trop Med Hyg 1995;52:405-13. 
2. Helmick CG, Bernard KW, D'Angelo LJ. Rocky Mountain spotted 
fever: clinical, laboratory, and epidemiological features of 262 cases. J 
Infect Dis 1984; 150:480-8. 
3. Treadwell TA, Holman RC, Clarke MJ, Krebs JW, Paddock CD, Childs 
JE. Summary of reported cases of Rocky Mountain spotted fever in the 
United States: 1993-1996. Am ] Trop Med Hyg. In press 2000. 
4. Census Bureau (US), Population Division, Administrative Records and 
Methodology Research Branch. 1990 to 1999 annual time series of 
state population estimates: race and Hispanic origin [cited 2000 Nov 
7]. Available from: URL: www.census.govlpopulation/www 
lestimatesist_srh.html 
5. Indian Health Service (US). Trends in Indian health: 1996. Rockville 
(MD): Department of Health and Human Services (US); 1997 
6. Indian Health Service (US). Hospital inpatient data tapes FY 
1980-1996. Rockville (MD): Indian Health Service; 1997. 
7. Indian Health Service. Regional differences in Indian health 1997. 
Rockville (MD): Indian Health Service; 1998. 
8. Public Health Service (US) and Health Care Financing Administration 
(US). International classification of diseases, 1997: 9th revision, clinical 
modification. 6th ed. [CD-ROM]. Washington: Public Health Service; 
1997. 
9. Census Bureau (US). Intercensual estimates of the population by state: 
1980-1996. Washington: Census Bureau; 1997. 
10. Kleinbaum DG, Kupper LL, Muller KE, Nizam A. Applied regression 
analysis and other multivariable methods. Belmont (CA): Duxbury; 
1998. 
11. Case definitions for infectious conditions under public health surveil- 
lance. MMWR Morb Mortal Wkly Rep 1997;46(RR-10):28-29. 
12. Lehmann EL, D'Abrera HJM. Nonparametrics: statistical methods 
based on ranks. San Francisco (CA): Holden-Day, Inc; 1975. 
13. Newhouse VF, Shephard CC, Redus MD, Tzianabos T, McDade JE. A 
comparison of the complement fixation, indirect fluorescent antibody, 
and microagglutination tests for the serological diagnosis of rickettsial 
diseases. Am J Trop Med Hyg 1979;28:387-95. 
14. Kaplowitz LG, Fischer JJ, Sparling PF. Rocky Mountain spotted fever: a 
clinical dilemma. Curr Clin Topics Infect Dis 1981;2:89-108. 
1S. Buller RS, Arens M, Hmiel SP, Paddock CD, Sumner JW, Rikihasa Y, et 
al. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N 
Engl J Med 1999;341:148-55. 
16. McQuiston JH, Paddock CD, Holman RC, Childs JE. Human ehrli- 
chioses in the United States. Emerg Infect Dis 1999;5:635-42. 
17. Harkess JR, Ewing SA, Crutcher JM, Kudlac J, McKee G, Istre GR. 
Human ehrlichiosis in Oklahoma. J Clin Infect Dis 1989; 159:576-8. 
18. Carpenter DF, Gandhi TK, Kong LK, Corey GR, Chen SM, Walker DH, 
et al. The incidence of ehrlichial and rickettsial infection in patients 
with unexplained fever and recent history of tick bite in central North 
Carolina. J Infect Dis 1999; 180:900-3. 
19. Fritz CL, Glaser CA. Ehrlichiosis. Infect Dis Clin North Am 
1998; 12:123-36. 
20. Eng TR, Harkess JR, Fishbein DB, Dawson JE, Greene CN, Redus MA, 
Satalowich FT. Epidemiologic, linical, and laboratory findings of human 
ehrlichiosis in the United States, 1988. JAMA 1990;264:225 1-8. 
21. Rotz L, McKechnie D, Wolfe D, Gaw E, Hathcock L, Childs J. An epi- 
demiologic and entomologic investigation of a cluster of Rocky Moun- 
tain spotted fever cases in Delaware. DE Med J 1998;70:285-9 1. 
22. Jones TF, Craig AS, Paddock CD, McKechnie DB, Childs JE, Zaki SR, 
Schaffner W. Family cluster of Rocky Mountain spotted fever. Clin 
Infect Dis 1999;28:853-9. U 
PUBLIC I-IEALTH REPORTS * SEPTEMBER/OCTOBER 2000 * VOLUME 1 15 475 
